Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel with or without Rocaltrol in advanced non-small cell lung cancer
ChiCTR2100051135Phase 2Recruiting
- Sponsor
- First Affiliated Hospital of Jinan University
- Start
- Jan 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in non-small cell lung cancer (NSCLC) comparing Group A: docetaxel with Group B: docetaxel + Rocaltrol (2 arms). Primary endpoint: Complete response. Started Jan 2020; status: recruiting.
02
Drugs
docetaxelcalcitriol
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR2100051135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051135.